In this podcast episode, CANCER BUZZ speaks with Emily Smith, MD, associate professor of Dermatology at St. Louis University School of Medicine, about best practices for early referral from dermatology and how to identify high-risk patients.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Effective partnerships between dermatologists and oncologists are an essential component of care coordination for patients with advanced non-melanoma skin cancers. This interprofessional collaboration can be more challenging in the community setting, where fewer resources are available in comparison to large academic medical centers. In this podcast episode, CANCER BUZZ speaks with Emily Smith, MD, associate professor of Dermatology at St. Louis University School of Medicine, about best practices for early referral from dermatology and how to identify high-risk patients.
“It’s impossible to read through every single journal that comes out every single day. There are really nice email listservs that [community] providers can sign up for that will provide updates—the American Academy of Dermatology host[s] guidelines for the care and management of different cancers: cutaneous squamous cell carcinoma [and] basal cell carcinoma being two of them, and they are updated on a cyclical basis. Those are great guidelines to just ensure…that they are reviewed and that current practices are following those guidelines.”—Emily Smith, MD
Guest:
Emily Smith, MD
Associate Professor of Dermatology
Department of Dermatology
St. Louis University School of Medicine
St. Louis, MO
This podcast was made possible with support from Regeneron.
Resources
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
